ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Dermatology, Neurology & Eyecare Therapies, Pharma & Supplement Portfolio Update

Valleant Health, in partnership with Tendimension, expands its pharmaceutical portfolio with new treatments for dermatology, neurology, and eye care, alongside natural supplements for prostate, tinnitus, and blood sugar management.

-- Valleant Health has expanded its portfolio of specialty pharmaceuticals and natural supplements, strengthening its position in the North American healthcare market. The company now offers advanced treatments for dermatology, neurology, and eye care conditions, alongside natural supplements for weight management, prostate health, tinnitus, and blood sugar stabilization.

For more information, visit https://tendimen.com/valleant-health

These new therapies demonstrate Valleant Health's investment in research and development for complex medical conditions. Their approach combines scientific methods with accessibility, providing patients with effective care without sacrificing quality or affordability, the team says.

The dermatology, neurology, and ophthalmology treatments developed by the team address specific patient needs with formulations that improve outcomes and quality of life. Supporting these pharmaceutical options, Valleant Health develops natural supplements with carefully selected ingredients that aid metabolism, prostate function, hearing comfort, and glucose management.

In particular, their weight management program combines supplements with nutrition plans for long-term results, and for prostate health, the company conducts thorough assessments and provides targeted treatments that address root causes while improving urinary function. The team has also developed tinnitus solutions that effectively decrease ear ringing through supplements and individualized care strategies.

Valleant Health also offers blood sugar management supplements and wellness plans to patients as an option to reduce medication dependence, supporting glucose metabolism and insulin sensitivity.

Medical professionals throughout North America now have access to these therapies, while Valleant Health continues to expand its footprint in global markets. The company continues to prioritize patient care through support programs that streamline access to treatment and encourage long-term adherence.

Valleant Health also builds partnerships with healthcare organizations across North America, creating collaborative opportunities with the goal of improving patient care through innovative treatment protocols. These partnerships further strengthen the company's ability to deliver personalized healthcare solutions that meet diverse patient needs.

To learn more about Valleant Health and their healthcare solutions, visit https://www.tendimen.com/valleant-health

Contact Info:
Name: Tendimension
Email: Send Email
Organization: Tendimension
Address: 11320 North FM 620 Suite F-104, Austin, Texas 78726, United States
Website: https://www.tendimen.com

Source: PressCable

Release ID: 89164095

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.